Chirag Shah, MD @CShahMD @ClevelandClinic @WhitworthMD @RRabinovitch @margenthalerj ASCO22 #OncoTwitter @oncoalert Assessing The Benefit Of AET

Chirag Shah, MD @CShahMD @ClevelandClinic @WhitworthMD @R...

3 الشهور
13 الآراء
Want to watch this again later?
Sign in to add this video to a playlist. تسجيل الدخول
0 0

Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at Cleveland Clinic. In this video, he speaks about the ASCO 2022 Abstract - Assessing the benefit of adjuvant endocrine therapy in patients following breast-conserving surgery with or without radiation stratified by a 7-gene predictive DCIS biosignature.